Achieving universal health coverage (UHC) requires Background: increased domestic financing of health by low-income countries (LICs) and middle-income countries (MICs). It is critical to understand how much governments have devoted to health from their own sources and how much growth might be realistic over time.
Background
Many low-income countries (LICs) and middle-income countries (MICs) have committed to the ambitious health-related Sustainable Development Goals (SDGs), such as the achievement of universal health coverage (UHC), which will require additional resources for health, alongside other measures. For example, Stenberg and colleagues estimate that it will cost an additional $371 billion annually across 67 LICs and MICs (those representing 95% of the population of all LICs and MICs) to strengthen health systems to achieve the health-related SDGs 1 . At the same time, some MICs are now transitioning out of grant or concessional external finance mechanisms, such as support from Gavi, the Vaccine Alliance, The Global Fund to Fight AIDS, Tuberculosis and Malaria, and World Bank International Development Association credits. Such MICs need to replace these sources of external finance with domestic financing. Given these twin shifts in global health-the adoption of highly ambitious health goals that necessitate scaled up financing, coupled with the transition of MICs away from development assistance for health (DAH)-there is intense interest in understanding the role of domestic finance for health in LICs and MICs in the SDGs era.
More specifically, it has become critical to understand how much governments have devoted to health from their own sources and how much growth might be realistic over time. This study aimed to elucidate these trends by examining the sources of financing for health from 2000 to 2015 in LICs and MICs, with a focus on government expenditure from domestic sources. Our goal was to understand the recent experience of LICs and MICs in financing their health sectors in order to better estimate the possible scope for future domestic resource mobilization.
This analysis was feasible because of the major effort that the World Health Organization (WHO) recently made to update and reorganize its Global Health Expenditure Database (GHED), which includes information on health spending from 192 WHO member states from 2000-2015. The GHED introduced major improvements in its December 2017 data release to follow the System of Health Accounts 2011 2 (SHA2011), which "tracks all health spending in a given country over a defined period of time regardless of the entity or institution that financed and managed that spending." Health expenditure estimates for 2000 to 2015 were revised to disaggregate expenditures by financing source (public, private, and external) as well as by financing scheme (the arrangements through which spending is made). The reorganization also separated out current expenditure (such as wages, goods, and services) from capital expenditure (such as investment in more durable equipment and infrastructure).
Our study complements the recent analysis that the WHO published on the new GHED, an analysis called New Perspectives on Global Health Spending for Universal Health Coverage 3 . Our study goes into more detail on financing sources, particularly the changes in government expenditure on health, relative to other indicators. We use data from the new GHED to explore (1) how government expenditure on health from domestic sources grew relative to both gross domestic product (GDP) and general government expenditure (GGE), and (2) how these indicators changed across income groups and countries. Our findings can be used to assess country progress against existing targets for domestic health spending, and to develop scenarios of domestic resource projections going forward.
In addition to mobilizing new resources for health, another way to expand fiscal space (budgetary room) for health is through efficiency gains. Our study does not examine such gains.
Methods
Our Methods sections have seven key steps. We first describe the GHED, including the sources of health expenditure reported in this database, since this is the key source of data for our study. Second, we explain the rationale for our sample size. Third, we describe how we grouped countries by income level. Fourth, we describe the completeness of the data used in our study. Fifth, we lay out the scope of our study and delineate the specific research questions. Sixth, we summarize how we calculated the key metrics in our study. Finally, we explain how we conducted a decomposition analysis using the data available within the GHED to identify the key drivers of growth in general government health expenditures.
The Global Health Expenditure Database The GHED was updated in December 2017 to disaggregate expenditures by financing source. The update furthermore disaggregated expenditures by financing arrangement and separated out recurrent (or current) expenditure from capital expenditure. Unless clearly stated as capital expenditures, the health expenditure indicators include only current expenditure. Current expenditures are made up of expenditures on resources that are consumed within one year, including wages, goods, and services. Capital expenditures are expenditures on assets such as buildings and equipment that have a working life of one year or longer. This distinction is intended to make current expenditure estimates more comparable year on year, as capital expenditures tend to be "lumpy." If capital expenditures and current expenditures were combined, an increase or fall in health expenditure could be due in part to the timing of infrastructure projects.
The indicator current health expenditure (CHE) consists of domestic general government expenditure (GGHE-D), health expenditure from external sources (EXT), and domestic private health expenditure (PVT-D) ( Figure 1 ). One point that is unclear in the GHED is how well external assistance is disaggregated between capital and current expenditure. 
Rationale for sample size
The GHED database contains 192 countries. We used two criteria to decide which countries would be included in our analysis:
i. The population of the country in year 2015 was more than 600,000. This threshold was chosen to harmonize our analysis with the analysis reported in WHO's global report New Perspectives on Global Health Spending for Universal Health Coverage; and
ii. Data for the indicators GDP, GGHE-D, CHE, and out-ofpocket expenditures (OOP) were available for years 2000 and 2015.
Once countries with population less than 600,000 in year 2015 were eliminated, the sample size for our study was reduced from 192 to 159. After eliminating countries with missing values, the sample size further dropped from 159 to 125. Table 1 lists the countries included in the analysis by income group, and also lists the countries excluded and the corresponding rationale.
Grouping of countries into income classifications
For grouping countries in the analysis, we used the World Bank analytical income classification system, which groups countries into low-income countries (LICs), lower-middle-income countries (LMICs), upper-middle-income countries (UMICs), and high-income countries (HICs According to their 2015 GNI p.c., only 31 countries were still in the LIC category by 2015, compared to 63 at the start of the study period in 2000 (Appendix 2 5 ). The rationale for defining income groups at the start of the period is so that the findings might be useful for projections. In doing projections, we can only know a country's income status at the start of the projection period, not at the end of the projection period.
We have created two additional income groups, namely, LICs without India (as India was classified as an LIC at the start of the period) and LMICs without China (as China was classified as an LMIC at the start of the period), to study the changes in health expenditures across the respective income groups excluding these two large economies and also to study changes in these two economies individually. While our study mostly examines the results for the different income groups and India and China, the GHED data can be used to examine health expenditure estimates for every individual country using our methodology. Country level results will vary from the respective income groups. Some of the variations observed for India and China when taken together with and separately from the LIC and LMIC groups respectively are discussed in the results and discussion sections. The accuracy of data reported in the GHED varies on a country-to-country basis. National Health Account exercises form the core of a solid understanding of sources of financing at the country level. Some countries have completed national health accounts (NHA) exercises multiple times, and others have yet to conduct them. Most countries publish expenditure data, but others only provide budgeted data. For cases where NHA data is not regularly available, WHO has filled missing data gaps by using government budget data, interpolations and data from international sources such as the Organization for Economic Cooperation and Development's Development Assistance Committee database, or through in-country consultations. Inevitably, some country data are much stronger than other country data.
Data completeness and accuracy

Scope and key research questions
This study first provides a general overview on changes in sources of financing, and then it more deeply analyzes the changes in GGHE-D. The GHED database contains several other important macro indicators, including GGE and GDP. For the purposes of the analysis, we primarily compare the growth in GGHE-D to the growth in GDP, the growth in GGHE-D to the growth in GGE, and the change in the share of GGHE-D to GGE. The GGE is intended to capture all government (federal, state, local) current expenditure. Our study aims to answer three main questions based on the analysis of these key GHED indicators:
1. How did the composition of current health expenditure change during the period 2000 to 2015?
2. How did health expenditures from various sources change over this time period?
3. What were the main sources of growth in GGHE-D during this period?
Calculation of metrics
To answer these three key questions, we looked at aggregate health expenditure estimates and ratios for the income groups defined above in sub-section (iii) and in two large economies, China and India. In this study, estimates are calculated for each income group as a unit. Our approach differs from the methodology used by WHO in their study New Perspectives on Global Health Spending for Universal Health Coverage; in that study, the WHO reports country-weighted averages. With country-weighted averages, a country such as India (1.3 billion population in 2015) is given the same weight in the LIC group as Comoros (800,000 population in 2015). In our method, a country with large expenditures would have greater weight than a country with smaller expenditures.
In order to aid comparison of our results with the WHO study and highlight the differences in methodologies of the two studies, some figures and tables in our study are intentionally designed to be similar to the ones used in the WHO study ( Figure 4 - Figure 6 and Appendix 3 5 ).
Figure 2 is a flowchart that summarizes data sources, country inclusion criteria, country classification by income, and calculation of key metrics used in this study. It includes the formulae used for calculating absolute values and ratios. For a given income group i, the estimated health expenditure value for year j is the summation of reported values for all countries in that income category included in our analysis. Ratios are then calculated by simple division of the particular estimated values. The formula used for calculating annualized rate of growth is available under Table 3 and Table 4 . The database and calculations used in this study can be viewed on OSF 5 .
Decomposition of change in GGHE-D between 2000 and 2015
In addition to comparing trends in health expenditure estimates over the 2000 and 2015 time period, we have also conducted a decomposition analysis using the data available within the GHED to identify the key drivers of growth in general government health expenditures. This analysis is reported by income groups and separately for India and China.
We have looked at three key drivers that impacted the iii. Changes in prioritization of health within government budgets measured by the ratio GGHE-D/GGE iv. Apart from these three key factors, some of the ΔGGHE-D can also be attributed to multiplier effects of economic growth leading to increased resource mobilization and higher government expenditures or more fiscal space for health expenditures. These interactions had been captured in our analysis after accounting for changes in GGHE-D from the three factors mentioned above.
The formulae used in the decomposition analysis are shown below:
1. ΔGGHE-D GDP : This value shows the change in GGHE-D due to economic growth alone, which is calculated by subtracting GGHE-D in year 2000 from the product of the GDP of year 2015, and the ratios GGE/GDP and GGHE-D/GGE in year 2000. 
ΔGGHE-D interactions :
This value shows the amount of ΔGGHE-D that can be attributed as an interaction between these terms influencing each other. This is calculated as the difference between the GGHE-D in year 2015 and the sum of ΔGGHE-D GDP, ΔGGHE-D GGE/GDP and
While the results of the decomposition analysis can vary from an individual country to country basis, the reporting by income groups helps us identify whether countries in general have been creating more fiscal space for health by reallocating government budgets towards health, strengthening tax bases, or whether growing government health expenditures are mostly spurred by economic growth alone.
Results
In this section, we divide the results of our study into five subsections. Annualized rates of growth of key indicators Annualized growth rates are useful to readily see how rapidly different sources of finance are growing relative to each other as well as relative to growth in population, GDP, and overall government expenditure. Some differentials in annualized growth rates are large, others in Table 3 Typically, as shown in a 2015 IMF report, as economies develop, the tax base expands and tax administration improves, and tax revenue as a share of GDP increases over time. Some countries that are highly dependent on natural resources, with undiversified economies, may be an important exception to this trend. In addition, a 2011 report from the IMF Fiscal Affairs Department found that many resource-rich countries struggle with greater volatility in tax receipts compared to other countries. In addition to tax revenue from economic growth, tax revenue from an expanded tax base can provide a source for increased domestic government health expenditures. The GHED does not have data on tax revenue, but it does have data on GGE. Tax revenue and GGE are distinct concepts as expenditure can exceed revenue if 
GDP, gross domestic product; GGE, general government expenditure; GGHE-D, domestic general government health expenditure; CHE, current health expenditure; OOP, out-of-pocket expenditure. 
governments run deficits. In all regions, GGE growth is faster than growth in GDP both in absolute and per capita terms, constant US$. The differential is largest in China, with GGE growing by almost 15% per year on average, exceeding GDP of about 10% per year. Table 4 presents ratios of key indicators. The ratio in the first column is the annualized growth in GGHE-D relative to GDP. In all cases, it is positive, but it is highest for China at 8% and lowest for India at 0.9%. The growth in GGHE-D relative to GGE is positive in all groups, meaning that as GGE grows, either the share going to GGHE-D grows faster or governments are allocating a higher share to health. This growth rate is highest for China.
The growth in GGHE-D relative to current health expenditure is relatively low but positive, except in the low-income group when India is excluded, where it is weakly negative. As mentioned previously, the growth of out-of-pocket spending relative to current health expenditure is negative in all groups, except for low-income groups once India is excluded, where it is close to zero.
Even among HICs, GGHE-D is growing faster than GDP and faster than GGE. Many HICs have achieved UHC or close to it, but demands for health, changes in real costs, technological change, and difficulties in cost containment can mean expenditures continue to rise faster than income growth. These challenges have been long-discussed, including by William Baumol in the early 1990s 2 .
Comparing financing trends from 2000-2015 with health spending targets Targets have been set for certain expenditure indicators in international forums and in international reports. For example, in April 2001, the heads of state of African Union countries pledged to allocate at least 15% of government budgets to health. Less often quoted from the Abuja meeting, but also important, was the call on donor countries to meet the target of at least 0.7% of GNP to official development assistance to developing countries (although the proportion to health was left ambiguous) 6 . The "Abuja" target of 15% has been widely referenced since this meeting in discussions about resource mobilization. Considerable emphasis is given to the policy lever of reallocation of overall government expenditures towards health in domestic resource mobilization discussions. As an example of another target, the 2010 World Health report suggested that over the long term, the level of combined government spending and compulsory insurance (which we include in public spending in our analysis) needs to reach 5 to 6% of GDP to achieve UHC 3 . Figure 5 shows government expenditure on health (from domestic and external sources) as a share of government expenditure. While some individual countries reached the target, the LICs and LMICs income groups are very far from the Abuja target in 2015 (i.e., allocation of 15% of the government budget to health). As shown in Figure 5 , between 2000 and 2015, this share increased from 4.8% to 5.2% for LICs and 8.6% to 10.4% for LMICs. The share for HICs (not shown in Figure 5 ) was over 20% in 2015. Similarly, apart from HICs, no other income group has met the target suggested in the 2010 World Health Report of combined government spending and compulsory insurance reaching 5-6% of GDP. However, this ratio is growing in most income groups. GGHE as a share of GDP rose slightly in LICs from 1.1% to 1.3% between 2000 and 2015. India brings down the estimate for LICs. After removing India, this share increases to 1.5% for LICs but is still much lower than the recommended level ( Figure 6 ).
Our study found some outlier countries where the level of level of general government health expenditure as a share of both GDP and general government expenditures seemed very low or very high. In some cases, the change (increase or decrease) in GGHE/GDP and GGHE/GGE between 2000 and 2015 was very dramatic. These 'outlier' countries are listed in Appendix 4 5 .
On the one hand, the performance of these countries may have varied greatly from the average values due to unique country experiences. On the other hand, data outliers can also point out possible data errors.
Key drivers of growth for the increases in GGHE-D from 2000 to 2015
With the GHED database, we can identify how much of the growth in GGHE-D, in real terms, from 2000 to 2015 is due to (i) economic growth alone, (ii) expansion in public spending measured by GGE/GDP, (iii) reallocation of GGE towards health measured by GGHE-D/GGE and (iv) interactions across these factors. Figure 7 shows the decomposition of GGHE-D growth between 2000 and 2015. Economic growth is the largest driver of increases in GGHE-D in LICs, LMICs, UMICs, and India. An illustration of the decomposition of the growth in GGHE-D for LICs is shown in Table 5 . In HICs, shifts in public spending towards health are also big drivers.
Between 2000 and 2015, China experienced rapid economic growth with a 300% expansion of the GDP, which likely fueled rapid expansion of government budgets with GGE/GDP growing by more than 6 times during this period. This high growth and budget expansion, along with rapid prioritization of health is reflected in the high value of the interactions in the GGHE-D decomposition for China shown in Figure 7 . Once China is separated from the LMIC country group, the interaction effect on GGHE-D growth diminishes greatly for the LMIC without China group.
Discussion
This study draws on data over the period 2000 to 2015 to examine how the composition of current health expenditure has changed, how health expenditures grew from different sources of financing, and what the main drivers of growth in GGHE-D were over this period. It presents results by broad income groups, with countries classified into groups by their income level at the start of the period.
The study finds that LICs, taken as a group, were left out of the significant shifts that occurred in other income groups in the share Given the importance of GGHE-D in universal health coverage, we attempted to disaggregate the main drivers of GGHD-D growth over the period. We wanted to understand how much of the growth is due to reallocation of government spending towards health in the government budget, which is something that gets much attention in policy discussions. We wanted to understand how much strengthened tax bases contribute to increased resources. And we wanted to understand the impact of economic growth. We developed a methodology to quantify these three components to growth in GGHE-D, with a fourth component that represents the interactions of these variables.
We find that economic growth was the largest single driver of increases in GGHE-D in LICs, LMICs, and UMICs. The strengthened tax base was most significant in UMICs. For HICs, where economic growth was relatively lower and tax bases were already strong, the largest driver was a greater share of GGHE-D out of government spending. In presenting our results, we also showed the findings for India and China separately. India was classified as an LIC at the start of the period, and China was classified as an LMIC. Both countries experienced rapid income growth but had divergent experiences in health expenditures.
The prioritization of health within the government budget was the key difference between China and India's experience from 2000-2015. China's increase in GGHE-D came not only from economic growth and growth in the share of GGE in relation to GDP, but also through prioritizing health within the government budget, and the interactions of these factors. India's growth in GGHE-D, however, was primarily due to economic growth.
Methodological approach
This study was possible because of the major changes to the WHO GHED database in the December 2017 release. Our study reports on what the data currently show, while recognizing that the data, inevitably, contain errors and will change and improve over time. With the exception of China and India, our study reports on income group results, rather than individual country results, because the purpose was to understand broad trends. We used GGE/GDP as an indicator of the tax base relative to GDP, because this data was available in the WHO GHED database, but it is only a proxy for the tax base, as expenditures (GGE) can, in some years, exceed revenue. Our approach for disaggregating the sources of growth of GGHE-D into economic growth, strengthened tax base, and reallocation within the government budget is new to this study.
Our study has focused on resource generation and not on the important issue of improving efficiency. Funds for priority health activities can also be made available from improvements in allocative efficiency (spending money on the right things) and technical efficiency (spending money to achieve results at lowest cost). Considerations of how to generate fiscal space for health at a country level ideally need both elements, revenue generation and efficiency measures.
Comparison with other studies WHO's study New Perspectives on Global Spending for Universal Health Coverage draws on the same database as this study. However, because of differences in methodological approaches, some of the findings are different. The WHO study classified countries into income groups by their income status at the end of the 2000 to 2015 period, and we chose to classify countries into income groups by their income status at the start of the period. More importantly, the WHO study used country-weighted averages of indicators, while we calculated indicators for the income group as a whole, so larger countries have a larger weight in our results, and smaller countries have a smaller weight. As an example of how the results differ because of these two differences in methodology, the WHO study found that OOP expenditures as a share of CHE fell from 46% to 38% over the period for LICs, while we found only a slight drop, from 60 to 58% (and the numbers are much higher). Differences in results between the two studies are not surprising, given that the WHO study used country-weighted averages while we calculated results for the income group as a whole, and also because countries were classified into income groups at different points in time. India is included in our LIC group because it was classified that way in 2000, while India is not in the WHO LIC definition, because it was no longer an LIC at the end of the period. India has a large weight in our calculations because of its large size, but India would be given the same weight as any other country in the WHO results. In terms of broad conclusions, there is more similarity across the two studies.
The WHO study, our study, and others 7,8 stress the importance of economic growth in driving GGHE-D growth relative to reallocation within the government budget. Looking forward, given the importance of economic growth in domestic resource mobilization, there is cause for concern in the poorer countries with slow or no growth projections and in conflict/fragile countries. Even in the poorer countries with rapid economic growth projections, it will take time to increase government budgets significantly given low starting points. External assistance for health needs to focus as much as possible on the poorest countries, and LICs and LMICs with unfavorable economic prospects.
Conclusions
Our study found that economic growth was the largest driver of growth in GGHE-D in LICs, LMICs, and UMICs over the period 2000 to 2015. While growth in CHE p.c. and GGHE-D p.c. was fastest in LICs and LMICs, the composition of CHE changed the least in LICs. In LMICs and UMICs, the share of OOP in CHE fell and the share of GGHE-D in CHE increased significantly over the period. However, in LICs these indicators changed only slightly, indicating lack of progress towards UHC as measured by these indicators. With the exception of China and India, our study looked at income group aggregates, and individual country experience will differ. The appendices to this report 5 present country indicators. The outliers in country results could indicate distinct experiences or problems with the dataset (as this dataset is relatively new, and the quality of data do vary by country).
Discussions about a government's ability to reallocate across government budgets need to be evidence based and pragmatic given the findings of the experience from 2000 to 2015. While there are exceptions, such as in China, most countries are moving very slowly towards prioritizing health more in government budgets. Our findings suggest that dialogue on domestic resource mobilization needs to be more balanced, with emphasis on overall economic growth and growth in the tax base as well as share of health in government budget. Arbitrary targets are unlikely to be helpful in these discussions.
This study reports primarily on results by country income group. A next step would be to delve into the differences within the groups to learn about important country differences in experiences and also to highlight possible errors in the data. The WHO GHED is an important public good and with further improvements in data accuracy over time, it will be an important tool for investigating important emerging trends of health expenditure around the world.
Data availability
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Extended data
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Aparnaa Somanathan
Health, Nutrition and Population Global Practice, World Bank, Washington, DC, USA This paper contains very valuable analyses of trends and composition of government health spending, as well as key underlying factors. The context and motivation for this paper are clearly laid out: the push for UHC-both at global and country levels -and the transition from donor financing in many cases. In terms of public policy, the past decade have been quite significant for UHC with many low and middle income countries committing at a very high level to achieving UHC. It is helpful to be able to look at how public expenditures have fared during this period and whether they have lived up to the UHC rhetoric. The analysis and findings of this paper are therefore quite relevant to the future of this debate.. I agree with the two other reviewers on the two substantive methodological issues they have raised:
The decision to use an expenditure-weighted series of indicators is problematic given that there is still quite a lot of heterogeneity within each income group even after excluding China, India and very small states. Each income groups contains countries with quite different public expenditure (general and health) trajectories and factors that drive those trajectories, making it difficult to draw meaningful conclusions about the group as a whole. I would agree with Bill Savedoff's recommendation that the revised version include country-weighted versions from the same data to assess the influence of the weighting method on results. The decomposition method needs to reflect on the broader literature on this topic and why this method was chosen. High-income countries are singled out when arguing that difficulties in cost containment may be a reason why GGHE-D is growing faster than GDP. While GGHE-D increases in middle income countries may have occurred because of high level public policy commitments to achieving universal coverage, the evidence, by and large, shows that cost-containment is very much a problem. Country-specific analyses (e.g. WB analysis for Vietnam and Indonesia) suggest that the lack of cost containment is undermining progress towards UHC in spite of large increases in GGHE-D. It would be important to clarify this point, even if efficiency improvements are not the focus of this paper.
Using increases in GGE as a proxy for strengthening the tax base and tax administration is not convincing. The authors do note the limitations of this method. I would recommend simply discussing 1.
2.
The paper is very well structured and presented in a very reader-friendly way. The description of the methodology is very clear and easy to follow.
We also appreciate the acknowledgement from the research team on WHO Global Health Expenditure Database. The highlighted outlines are also very helpful for the countries and WHO team to further investigate the improve the data quality.
We would like to raise two methodological matters
The unit of the analysis On the unit of analysis, we agree with Bill Savedoff's comment. Based on the research objectives the country as the analysis unit is more appropriate. Although the authors provided sensitivity test by excluding India and China, and excluded countries less than 600,000 population, still the difference in population size among countries are huge. For example, the population in Lao PDR is less than 7 million while in Bangladesh is about 160 million. We suggest the authors use unweighted estimation with country as the analysis unit.
The decomposition analysis
We are not convinced that the method used for the decomposition analysis is desirable. The growth of GDP, GGE share in GDO and GGHED share in GGE are not linear addition. The GGHED increase is a production of GDP increase, GGE/GDP increase and GGHED/GGE increase. The equation would be as the following: gghed1/gghe0=(1+a)*(1+b)*(1+c) a, b and c are the increase of the three parameters, respectively. ln(ffhed1)-ln(gghed0)=ln(1+a)+ln(1+b)+ln(1+c)
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William Savedoff
Center for Global Development, Washington, DC, USA This paper describes changes in public health spending from 2000 to 2015 for country income groups, with separate analyses for India and China. It shows that public health spending grew significantly over this period in all income groups and mainly in association with rising national incomes. Lower Middle Income countries and Upper Middle Income countries had lower out-of-pocket spending and a rise in domestically-financed public health expenditure. Rising fiscal capacity (share of overall government spending in the economy) was only a significant factor in upper-middle-income countries; while policies reallocating public budgets toward health appear to have only been significant in high-income countries.
The article offers a clear set of questions and sets out to answer them with appropriate data and methods.
The article is clear and informative about the new database it employs, the country sample, and the methods of calculation. This should make it possible for readers to assess the results and interpret them appropriately.
It further provides appropriate qualifications about the data and alerts readers to the fact that its scope is limited to questions of the level of resources used for health and does not encompass questions of how efficiently that money is spent.
Nevertheless, I have several reservations about the paper related to its choice of weighting, the interpretation of the decomposition results, and lack of reference to the broader literature on health spending and economic growth.
Choice of weighting
My main reservation about the paper is the decision to calculate indicators with country income-group aggregates, effectively choosing an expenditure-weighted series of indicators.
The choice of weights is usually determined by the question that is being posed. If the question is about policy-making units of analysis, it would seem better to use country-weighted indicators. If the question is about the typical experience of a person in a given group of countries, then a population-weighted indicator would be better. I could think of reasons for choosing expenditure-weighted indicators as done by these authors, but none of those reasons seem relevant to the issues raised in the paper. Implicitly, the authors recognize the problems with their expenditure-weighting by taking India and China out of the income groups. However, this left me wondering, each time I read a finding, about the degree of out of the income groups. However, this left me wondering, each time I read a finding, about the degree of heterogeneity that remains in each group. For example, after excluding India, the low-income country grouping results are probably more representative of Indonesia or Ukraine than Chad or Lesotho. A country-weighted indicator would avoid this problem by producing a mean effect across policy-relevant units of analysis, i.e. countries.
If the authors choose to keep this weighting choice, then interpretations of the results should be consistent with this choice. For example, consider the following sentence:
"While the results of the decomposition analysis can vary from an individual country to country basis, the reporting by income groups helps us identify whether have been creating more fiscal countries in general space for health by reallocating government budgets towards health, strengthening tax bases, or whether growing government health expenditures are mostly spurred by economic growth alone. [italics added]"
The phrase "countries in general" is somewhat misleading because it implies we have learned something about a typical country in this group. To be accurate, the sentence would have to replace "countries in general" with something like "countries in each income group when aggregated together" or "higher-spending countries in this income group."
Similarly, the sentence on p. 11 offers the possibility that, "governments are allocating a higher share to health" when in fact the indicator shows only that might be allocating a higher-spending governments higher share to health.
All of this may be of little importance if the country spending within each income group is relatively homogeneous. The authors helpfully presented graphs (Figures 4 through 6) in the same format as those in a WHO 2018 report which used country-weighted indicators. This allows readers to see that the trends look somewhat similar. However, that comparison is affected by more than just the weighting choice. In a revised version, the authors could give readers a sense of how much the expenditure-weighting approach affects the results by presenting more information about the divergence between their calculations and the WHO 2018 report or, better yet, by calculating the country-weighted version from their own data and assessing the influence of the weighting method on results.
Decomposition method
The authors seek to measure the relative contribution of economic growth, fiscal capacity and budget allocations to the observed increase in government health expenditure. They do this with an identity that relates government health spending to GDP, government spending as a share of GDP, and government health spending as a share of total government spending. They then calculate three counterfactuals, each one a hypothetical government health spending level that changes one factor to its 2015 level while keeping the other factors at their 2000 levels.
This method is one reasonable way to answer their question (i.e. how much do the changes in public health spending have to do with economic growth relative to public choices about taxation and spending allocations?). However, the paper presents the method as if it were an obvious choice and as if a larger literature trying to address this question does not exist. The same question has been addressed by simulations, statistical analyses, and other decompositions in the literature (see references below). Why was this particular approach chosen?
The authors may also have mischaracterized the residual category in the decomposition analysis. The paper talks about this residual as if it were due to "multiplier effects" -which is not true (at least not in the paper talks about this residual as if it were due to "multiplier effects" -which is not true (at least not in the macroeconomic sense) -and "interactions" -which is somewhat vague. At root, I suspect the residual is actually due to an index problem, not unlike the indeterminacy of inflation calculations using Paasche and Laspeyres indices. I believe that works by Das Gupta cited below (1991 and 1993 ) explain why such a decomposition for more than two factors is necessarily inconsistent. My understanding is that when variables change in small increments, the decomposition will successfully and intuitively account for a large share of the overall changes. However, when variables change in large amounts, the inconsistencies in the decomposition effectively swamp the utility of the calculation. If I'm right, then since some countries experienced massive transformations over this period and others much less, the ability to make judgments regarding the relative importance of the underlying factors is compromised. For example, the main thing that is apparent when comparing India and China is the large difference in the residual category which makes it difficult to say much about the relative amounts that can be associated solely with growth or budget changes. By aggregating countries into large income groups, the problem of the residual is attenuated but at the cost of masking heterogeneity within those groups.
Health spending and national income
Despite investigating the widely-debated relationship between national income and health spending, the paper only mentions one theory on this topic, that of William Baumol. However, Baumol's work is only one of many on this topic and whether or not his argument applies to health spending (where productivity has, indeed, been growing by many measures) is contested. More relevant references that could inform the If the authors choose to revise the paper, these are some smaller issues that they might want to consider addressing as well:
I found Figure 1 to be very confusing. Since these are accounting definitions, it should be possible to present them in a clearer hierarchical ordering. The position of boxes and the directions of arrows did not make sense to me.
The authors might want to alert readers that the term "domestic general government health expenditure" encompasses more than direct spending by the government through a ministry of health or national health system. It also includes spending by social security institutions, publicly-financed sickness funds, and compulsory contributions to non-governmental institutions. Figure 1 lists the codes associated with these different categories (FS.1, FS.3, FS.4), but most readers will not know the coding systems. It would only take a sentence to explain and could forestall potential confusion.
I believe the section comparing health financing indicators with targets leads policy discussions down a dangerous path and would recommend simply eliminating it. There is no technical basis for setting the Abuja target or the WHO "share of GDP spent on health" figure. The Abuja targets can lead to absurd policy conclusions (e.g. a country can look better on the health budget share by making draconian cuts in pensions and education). Furthermore, the failure to reach a certain share of GDP contains no particular information at all (see Savedoff 2007 for an explanation of the origin of this WHO "target" and why the measure is not helpful).
